W. Worner et al., SELECTIVE DETERMINATION OF NONENZYMATIC GLYCOSYLATED SERUM-ALBUMIN ASA MEDIUM-TERM INDEX OF DIABETIC CONTROL, International journal of clinical pharmacology, therapy and toxicology, 31(5), 1993, pp. 218-222
Serum proteins are non-enzymatically glycosylated dependent on the con
centration of free glucose and measurements of their concentration are
used to control diabetic carbohydrate metabolism. Eight patients with
insulin-dependent diabetes mellitus (IDDM) and 8 patients with non-in
sulin-dependent diabetes mellitus (NIDDM) with glycosylated hemoglobin
levels of at least 10.5% were studied during a 6-week period of antid
iabetic therapy. Glycosylated serum albumin (GSA) and glycosylated tot
al serum proteins (GSP) were measured weekly using an affinity chromat
ography procedure. The fructosamine test (FA) and the measurement of m
ean blood glucose (MBG) were also carried out weekly. Glycosylated hem
oglobin and its glucose adduct HbA1c were determined at 14-day interva
ls (HPLC-method). All measured parameters decreased during the period
of the study. The correlation coefficients for the glycosylated protei
ns versus the MBG determined one week earlier were highest for GSA [ID
DM: r(GSA/MBG-1) = 0.726, p<0.001 for the single values and 0.984, p<0
.001 for the mean values; NIDDM: r (GSA/MBG-1) = 0.636, p<0.001 for th
e single values and 0.986, p<0.001 for the mean values]. The differenc
es between the IDDM and NIDDM group probably occurred because 6 NIDDM
patients were taking glibenclamide (7.0-10.5 mg/day) which is known to
inhibit the glycosylation reaction of albumin. The fructosamine test
is more prone to interferences than the selective determination of GSA
. GSA determination therefore, gives precise data in medium term diabe
tic control.